ZYDUSLIFEBSEZydus Lifesciences LtdHighPositive
Announced Tue, 19 May · 19:10 IST

Intention of promoters to participate in buyback

Corporate Actions View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹1017.70
prior close
₹1066.15
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.8+0.7+2.0+1.9+2.1+5.2+5.8+6.8+7.0+8.9+6.7+12.9
Up moveDown movePending
AI summary

Zydus Lifesciences has announced that its promoter group and persons in control have communicated their intention to participate in the company's buyback programme. The buyback involves up to 95,65,217 equity shares (0.95% of total paid-up capital) at INR 1,150 per share for an aggregate amount not exceeding INR 1,100 crores. The buyback is being conducted via the tender offer route under the Companies Act, 2013 and SEBI Buy-back Regulations. This intimation follows the board's approval and confirms promoters will tender their shares up to their respective holdings or lower as permitted by law.

Likely market impact

Promoter participation signals confidence in the company's value and can support the stock price. The INR 1,100 crore buyback (at a significant premium to face value of INR 1) is positive for remaining shareholders as it reduces share count and returns capital.